VIRGINIA (GNB)- A 45-year-old woman in Virginia who got a Johnson & Johnson shot in early March died, according to CDC’s Vaccine Adverse Event Reporting System.
A week after getting the shot, she got a severe headache and ended up going to the hospital for it. She had blood clotting and a low platelet count, and she died about two weeks after getting the vaccine.
According to CDC’s Vaccine Adverse Event Reporting System, below diagnosis is noted:
Diagnosis: Cortical vein thrombosis, massive intracerebral hemorrhage with tentorial herniation, thrombocytopenia. Clinical Presentation and Course: 1 week after receiving Janssen COVID19 vaccination, patient developed gradually worsening headache. On March 17th, patient presented to Hospital with dry heaving, sudden worsening of headache and L sided weakness. Evaluation with head CT revealed a large R temporoparietal intraparenchymal hemorrhage with 1.3cm midline shift. She ended up getting intubated for worsening mental status. On evaluation at arrival in Medical Center, she was noted to have extensor posturing. Repeat imaging revealed worsening midline shift to 1.6cm. CTA showed cortical vein thrombosis involving the right transverse andsigmoid sigmoid sinus with tentorial herniation. Patient developed brain herniation and brain death was pronounced on March 18th, 2021.
The US Food and Drug Administration and the US Centers for Disease Control and Prevention have paused the use of Johnson & Johnson’s Covid-19 vaccine over “rare and severe” type of blood clot.
“These types of reactions could be a rare autoimmune reaction. They emphasize that these events are “extremely rare”, FDA officials said Tuesday.
The Centers for Disease Control and Prevention says the blood clots are extremely rare but that it is reviewing the cases. The agency says it expects this pause to last for “a matter of days.”
In a statement, FDA said 6.8 million doses of the J&J vaccine have been administered and the agency is investigating six reported cases of a rare and severe blood clot occurring in patients who received the vaccine.
The CDC’s principal deputy director, Dr. Anne Schuchat, says the pause is intended “to prepare the health care system to recognize and treat patients appropriately.”
CDC and FDA have said in a joint statement, “Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.html.”
A global media for the latest news, entertainment, music fashion, and more.
